(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 16.86% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.15%.
Axogen's revenue in 2026 is $238,105,000.On average, 12 Wall Street analysts forecast AXGN's revenue for 2026 to be $14,680,801,872, with the lowest AXGN revenue forecast at $14,068,725,117, and the highest AXGN revenue forecast at $15,185,459,421. On average, 12 Wall Street analysts forecast AXGN's revenue for 2027 to be $17,232,805,645, with the lowest AXGN revenue forecast at $16,192,115,630, and the highest AXGN revenue forecast at $18,083,119,051.
In 2028, AXGN is forecast to generate $20,353,812,136 in revenue, with the lowest revenue forecast at $18,948,854,026 and the highest revenue forecast at $21,558,289,850.